Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

ITUS Executive Chairman Dr. Amit Kumar Appointed to American Cancer Society National Board of Directors

JPPYY

LOS ANGELES, CA--(Marketwired - November 30, 2016) - ITUS Corporation ("ITUS") (NASDAQ: ITUS), today announced that Dr. Amit Kumar, the company's Executive Chairman, has been appointed to serve on the National Board of Directors of the American Cancer Society.

The American Cancer Society is the largest voluntary health organization in the United States and is dedicated to eliminating cancer as a major health problem. The American Cancer Society's many activities include: (i) helping people through every step of their cancer experience; (ii) developing guidelines for recommended cancer screening tests; (iii) funding and conducting research to help better understand, diagnose, prevent, and find cures for cancer; and (iv) working with lawmakers to pass laws to defeat cancer and rally communities worldwide to join the fight against cancer.

"I am pleased and honored to be appointed to the Board of the ACS," stated Dr. Kumar. "The ACS is the largest non-government funder of cancer research, and as a Board Member, I am looking forward to helping advance the mission against cancer."

Headquartered in Atlanta, Georgia, the American Cancer Society has regional and local offices throughout the country that support 11 geographical divisions and ensure a presence in every community.

ITUS Corporation

ITUS funds, develops, acquires, and licenses emerging technologies in areas such as biotechnology. The Company is developing a platform called Cchek™, a series of non-invasive, blood tests for the early detection of solid tumor based cancers, which is based on the body's immunological response to the presence of a malignancy. Additional information is available at www.ITUScorp.com.

Forward-Looking Statements: Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect ITUS Corporation's current expectations concerning future events and results. We generally use the words "believes," "expects," "intends," "plans," "anticipates," "likely," "will" and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in "Item 1A - Risk Factors" and other sections of our Annual Report on Form 10-K for the fiscal year ended October 31, 2015 as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this press release.

ITUS Corporation: FOCUSED ON INNOVATION™

Contact:
Dean Krouch
310-484-5184
dkrouch@ITUScorp.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today